Abstract
Triflavin, a 7.5-kD cysteine-rich polypeptide purified from Trimeresurus favoviridis snake venom, belongs to a family of Arg-Gly-Asp-(RGD)-containing peptides, termed disintegrins. In this study, aggregating human platelets dose-dependently induced vasoconstriction in de-endothelialized isolated rat thoracic aortas. At 5x10(7) cells per milliliter, platelets induced a peak tension averaging 65 +/- 7.2% of the tension induced by phenylephrine (10 mumol/L). The relative effectiveness of RGD-containing peptides (including venom peptides triflavin and trigramin, small RGD synthetic peptides Gly-Arg-Gly-Asp-Ser [GRGDS], Gly-Arg-Gly-Asp-Phe [GRGDF], and Gly-Arg-Gly-Asp-Ser-Pro-Lys [GRGDSPK]) was examined by testing the inhibitory effect on aggregating platelet-induced vasoconstriction in de-endothelialized aorta. Triflavin (1 mumol/L) significantly inhibited the platelet-induced vasoconstriction, whereas neither trigramin (10 mumol/L) nor small RGD peptides (2 mmol/L) (i.e., GRGDS, GRGDF, and GRGDSPK) showed any significant effect. The release of serotonin and the formation of thromboxane A2 from aggregating platelets were both significantly inhibited by triflavin (2 mumol/L), whereas trigramin and small RGD-containing peptides showe...Continue Reading
References
Sep 17, 1976·Science·E F EllisJ A Oates
Dec 15, 1992·Biochemical and Biophysical Research Communications·J R SheuT F Huang
Jul 15, 1991·The Biochemical Journal·T F HuangC M Teng
Aug 22, 1991·Biochemical Pharmacology·T F HuangC M Teng
Apr 1, 1991·Journal of the American College of Cardiology·H Shimokawa, P M Vanhoutte
May 31, 1990·Biochimica Et Biophysica Acta·J WilliamsS Niewiarowski
Nov 1, 1990·Proceedings of the Society for Experimental Biology and Medicine·R J GouldS Niewiarowski
Sep 1, 1985·Cell·J M Gardner, R O Hynes
Mar 28, 1986·Science·R PytelaE Ruoslahti
Oct 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·B H ChaoJ M Maraganore
Jan 24, 1989·Biochemistry·T F HuangS Niewiarowski
Aug 1, 1986·British Journal of Haematology·K S SakariassenJ J Sixma
Feb 27, 1987·Cell·R O Hynes
Aug 1, 1986·The Journal of Clinical Investigation·D S HoustonP M Vanhoutte
Jul 30, 1982·European Journal of Pharmacology·R M Brazenor, J A Angus
Jul 1, 1983·The Journal of Clinical Investigation·Z M RuggeriR R Montgomery
Feb 1, 1982·The Journal of Clinical Investigation·R L Nachman, L L Leung
Jul 15, 1983·Science·R A CohenP M Vanhoutte
Sep 1, 1983·Naunyn-Schmiedeberg's Archives of Pharmacology·G EngelP A Stadler
Feb 1, 1993·Journal of Cardiovascular Pharmacology·B C YangJ L Mehta
Jan 1, 1994·Peptides·J R SheuT F Huang
Jan 1, 1994·The Journal of Pharmacy and Pharmacology·J R Sheu, T F Huang
Sep 1, 1993·Journal of the American College of Cardiology·E RaymenantsJ L Mehta
Dec 27, 1995·European Journal of Pharmacology·J R SheuT F Huang
Citations
May 10, 2001·International Journal of Hematology·J R SheuM H Yen
May 31, 2003·International Journal of Hematology·Joen R SheuMao H Yen
Apr 19, 2003·European Journal of Pharmacology·George HsiaoJoen-Rong Sheu
Feb 5, 1999·European Journal of Pharmacology·L W LeeJ R Sheu
Apr 8, 2003·Thrombosis Research·Woei-Jer ChuangJoen-Rong Sheu
May 16, 2008·Coronary Artery Disease·Jie ShenWei Feng Shen
Jul 23, 2003·Anesthesia and Analgesia·Greg Stratmann, George A Gregory
Aug 21, 2002·Biological & Pharmaceutical Bulletin·George HsiaoJoen-Rong Sheu
Sep 18, 2007·British Journal of Haematology·Ming Y ShenJoen R Sheu
Sep 22, 2007·The Journal of Pharmacy and Pharmacology·Chi-Feng PanJoen-Rong Sheu
Sep 11, 2020·International Journal of Molecular Sciences·Augusto Martins LimaNikolaos Stergiopulos
Apr 3, 2001·The Journal of Laboratory and Clinical Medicine·J R SheuC H Lin